Skip to main content
Lot GL342 Save $38.75 Glow Blend 70mg Research Peptides
Research peptide · Lyophilized

Glow Blend 70mg Research Peptides

Glow Blend — USA Made, ≥99% Purity

4.9 177 verified reviews
  • 70mg three-component blend: GHK-Cu 50mg + BPC-157 10mg + TB-500 10mg
  • USA manufactured in GMP-certified California and Arizona laboratory facilities
  • ≥99% component purity target with HPLC, mass spectrometry, and combined batch COA
$154.99 $193.74 Save $38.75
Manufactured in a GMP facility · Independently tested · Batch COA
Dispatched from a US warehouse within 48 hours, tracked
Certificate of analysis for lot GL342 below
Disclaimer

For research purposes only. Not intended for human consumption, medical use, diagnosis, treatment, or prevention of disease.

Specifications

Lot GL342
Purity target
≥99%
≥99% per peptide component (3rd-Party HPLC Tested)
Components
3
GHK-Cu: 402.92 g/mol; BPC-157: 1,419.5 g/mol; TB-500: 889.01 g/mol
Vial content
70 MG
Lyophilized Powder
Sequences
GHK-Cu: Gly-His-Lys·Cu²⁺; BPC-157: GEPPPGKPADDAGLV; TB-500: Ac-LKKTETQ
CAS
GHK-Cu: 89030-95-5; BPC-157: 137525-51-0; TB-500: 885340-08-9
Molecular mass
GHK-Cu: 402.92 g/mol; BPC-157: 1,419.5 g/mol; TB-500: 889.01 g/mol
Purity target
≥99% per peptide component (3rd-Party HPLC Tested)
Form
Lyophilized Powder
Origin
Manufactured, Formulated & Packaged in CA/AZ, USA
Storage
Store at -20°C (Freeze) or 2–8°C (Refrigerated) protected from light

What is Glow Blend?

Glow Blend is a 70mg multi-peptide research formulation containing GHK-Cu 50mg, BPC-157 10mg, and TB-500 10mg. It combines a copper tripeptide, a 15-residue peptide, and the seven-residue Ac-LKKTETQ fragment in one lyophilized vial.

Each ingredient keeps its own chemical identity after blending. The formulation allows researchers to investigate copper coordination, extracellular-matrix signaling, vascular pathways, and actin-related cell behavior within a single controlled design.

How It Works

01

GHK-Cu: Coordinates copper and is studied in fibroblast, gene-expression, and extracellular-matrix remodeling models.

02

BPC-157: Preclinical work examines VEGFR2, Akt/eNOS, nitric-oxide, and cell-migration signaling.

03

TB-500: Ac-LKKTETQ represents a thymosin beta-4 actin-binding region studied in cytoskeletal and motility research.

Analytical data

Every lot, on the record

Independent third-party HPLC evaluates the purity target, while mass spectrometry confirms molecular identity. Both results are documented in one combined, batch-specific Certificate of Analysis.

Glow Blend 70mg Research Peptides
Lot GL342 · Freedom Diagnostics Testing
VERIFIED
Purity (HPLC-UV)
99.76%
Net content
GHK-Cu - 56.40 mg BPC-157 - 10.26 mg Thymosin Beta-4 - 10.74 mg
Reported
2026-06-01
Identity (LC-MS)
Confirmed
Appearance
Blue Lyophilized Powder
HPLC MS
Analyte Method Specification Result Pass/fail
Identity LC-MS GHK-Cu/Thymosin Beta-4/BPC-157
Purity HPLC-UV 99.76%
Net Content GHK-Cu - 56.40 mg, BPC-157 - 10.26 mg, Thymosin Beta-4 - 10.74 mg
Chromatogram thumbnailChromatogram Chromatogram, full size
Mass confirmation thumbnailMass confirmation Mass confirmation, full size
Download COA (PDF)

Why Source from 321 Peptides?

Three components, one domestic chain of custody.

Every ingredient is manufactured and finished in GMP-certified California and Arizona facilities, never sourced from overseas or Mexico.

Transparent composition.

Third-party HPLC evaluates each component’s ≥99% purity target, and mass spectrometry verifies identity. One combined batch COA documents the 50mg + 10mg + 10mg formulation.

Lyophilized to protect the blend.

Freeze-drying supports stability across all three components during storage and transit. Domestic fulfillment keeps delivery fast and accountable.

Lot history 4 released lots

Every batch released under this compound, with the figure reported for each.

Lot Reported Purity Net content COA
GL342 2026-06-01 99.76% GHK-Cu - 56.40 mg, BPC-157 - 10.26 mg, Thymosin Beta-4 - 10.74 mg PDF
GL-49504 Superseded 2026-05-06 99.46% 70.49 mg Pending
GL-50081 Superseded 2026-05-02 99.58% 70.56 mg Pending
GL-48927 Superseded 2026-04-08 99.49% 70.42 mg Pending

Frequently Asked Questions

What is in Glow Blend 70mg?

Glow Blend contains GHK-Cu 50mg, BPC-157 10mg, and TB-500 10mg. Together, the three research compounds total 70mg per vial.

Does Glow Blend create a new peptide?

No, blending does not chemically join the three ingredients into a new peptide. GHK-Cu, BPC-157, and TB-500 retain their separate molecular identities.

Is Glow Blend FDA approved?

No, Glow Blend is not an FDA-approved drug or cosmetic product. It is offered exclusively for controlled non-clinical research.

Which COA applies to my vial?

The lot code printed on the vial. Select it above and the certificate for that batch is returned, including the chromatogram it came from.